Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$37.88 - $43.77 $5.28 Million - $6.1 Million
-139,397 Reduced 96.02%
5,785 $247,000
Q4 2023

Feb 09, 2024

BUY
$31.71 - $38.95 $3.79 Million - $4.65 Million
119,500 Added 465.31%
145,182 $5.61 Million
Q3 2023

Nov 13, 2023

BUY
$37.32 - $49.29 $650,860 - $859,617
17,440 Added 211.6%
25,682 $969,000
Q2 2023

Aug 10, 2023

BUY
$39.98 - $47.68 $329,515 - $392,978
8,242 New
8,242 $375,000
Q4 2022

Feb 10, 2023

BUY
$49.7 - $57.71 $449,387 - $521,813
9,042 New
9,042 $460,000
Q3 2021

Nov 12, 2021

SELL
$73.77 - $83.61 $2.83 Million - $3.21 Million
-38,382 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$80.5 - $88.01 $7.46 Million - $8.15 Million
-92,649 Reduced 70.71%
38,382 $3.09 Million
Q1 2021

May 13, 2021

SELL
$76.38 - $86.03 $5.59 Million - $6.3 Million
-73,231 Reduced 35.85%
131,031 $11.1 Million
Q4 2020

Feb 16, 2021

BUY
$75.39 - $82.36 $10.4 Million - $11.3 Million
137,656 Added 206.67%
204,262 $16.4 Million
Q3 2020

Nov 12, 2020

SELL
$78.33 - $90.73 $522,382 - $605,078
-6,669 Reduced 9.1%
66,606 $5.36 Million
Q4 2019

Feb 12, 2020

BUY
$76.7 - $88.45 $5.62 Million - $6.48 Million
73,275 New
73,275 $6.13 Million
Q3 2018

Nov 13, 2018

SELL
$70.71 - $77.75 $17.4 Million - $19.1 Million
-245,500 Closed
0 $0
Q2 2018

Aug 02, 2018

SELL
$63.43 - $75.41 $14.6 Million - $17.3 Million
-229,675 Reduced 48.33%
245,500 $18.1 Million
Q1 2018

May 14, 2018

BUY
$62.56 - $72.26 $1.99 Million - $2.3 Million
31,800 Added 7.17%
475,175 $30.9 Million
Q4 2017

Feb 09, 2018

SELL
$61.45 - $66.05 $3.13 Million - $3.36 Million
-50,875 Reduced 10.29%
443,375 $28.7 Million
Q3 2017

Nov 14, 2017

BUY
$59.5 - $64.61 $4.01 Million - $4.35 Million
67,375 Added 15.78%
494,250 $31 Million
Q2 2017

Aug 14, 2017

BUY
N/A
426,875
426,875 $25.8 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $18.2B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.